Premier Healthcare Database (COVID-19): Data that Informs and Performs
As the number of infected patients and deaths continue to rise globally, clinicians, scientists and researchers worldwide are struggling to understand all facets of COVID-19. Having sufficient data is the first step to evaluating the impact of COVID-19 and designing adequate local and national public health responses for the management and containment of this pandemic. The Premier Healthcare Database (PHD) is equipped with HIPAA-compliant, de-identified patient data to support COVID-19-related research needs.
Whether your organization is interested in evaluating novel testing and treatment options, supplying health systems with life-saving medications and equipment, or in ensuring patients are able to continue to manage their chronic conditions, download this white paper for a detailed description of the attributes and capabilities of the PHD as it relates to COVID-19 data.